Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ: BNGO )

0.2024 +0.0007 (+0.35%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Windtree Therapeutics (NASDAQ:WINT) shares rose 35.85% to $2.69 during Friday's regular session. Trading volume for this security as of 12:30 EST is 117.5... 
Via Benzinga
Bionano Stock Is Enticing on Strong Q1 Results and Saphyr’s Progress
Demand for Bionano's Saphyr tool is climbing, while new, potentially life-saving uses are being found for it. 
Via InvestorPlace
Could Bionano Genomics Be a Millionaire-Maker Stock?
This provider of genome mapping tools is showing signs of exponential growth ahead. 
Via The Motley Fool
The Bear Case For Bionano Genomics Carries More Weight
Bionano Genomics will have to show how its products are different than the competition if BNGO stock is to hold on to its recent gains. 
Via InvestorPlace
4 Biotech Stocks Wall Street Analysts Predict Will Gain More Than 60%
The integration of technology and successful clinical trials for treating critical ailments have boosted Wall Street’s optimism about several biotech stocks. Analysts expect Bionano, Cerus, Agenus and... 
Via Talk Markets
Why BioNano Genomics Traded Higher Today
BioNano Genomics Inc (NASDAQ:BNGO) shares traded higher by... 
Via Benzinga
Is Reddit Favorite BioNano Genomics About To Nosedive?
BioNano Genomics (NASDAQ:BNGO) is testing an important sup... 
Via Benzinga
Bionano Genomics Moves Into Speculative Buy Territory
Bionano Genomics recently reported healthy Saphyr Systems sales in the first quarter. As a result, BNGO stock gained over 20%. Is it a buy? 
Via InvestorPlace
74 Biggest Movers From Friday
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares... 
Via Benzinga
Bionano Genomics Just Can’t Kick the Cash-Raising Bug With All Its Dilution
Bionano Genomics can't kick the cash-raising bug. BNGO stock could fall to $1.85, its potential cash per share if it continues to raise cash. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Atea Pharmaceuticals (NASDAQ:AVIR) stock moved upwards by 24.11% to $23.86 during Friday's regular session. The current volume of 967.7K shares is 156.13% of... 
Via Benzinga
Why Bionano Genomics Stock Is Skyrocketing Today
The company reported better-than-expected Q1 revenue growth. 
Via The Motley Fool
Why Bionano Genomics, CorMedix and Eloxx Are Moving Friday
Bionano Genomics, Inc. (NASDAQ: BNGO), CorMedix Inc. (NASDAQ: CRMD) and Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) are among the health care movers Friday. Bionano Moves On Q1... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Biolase (NASDAQ:BIOL) shares increased by 27.6% to $0.74 during Friday's pre-market session. The company's market cap stands at $111.4 million. As per the... 
Via Benzinga
54 Stocks Moving In Friday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) shares jumped 44.5% to $12.93 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares jumped 39.8% to $4.04. MoSys, last week... 
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales. Bionano Genomics, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
Here's What Investors Liked About Bionano Genomics' Q1 Results
The company delivered a pleasant surprise. 
Via The Motley Fool
Bionano Genomics, Inc (BNGO) Q1 2021 Earnings Call Transcript
BNGO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
13 Stocks Moving In Thursday's After-Hours Session
Gainers DoorDash (NYSE: DASH) shares are trading higher after the company reported better-than-expected Q1 sales results. Bionano Genomics (NASDAQ: BNGO) shares are trading higher... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Bionano Genomics (NASDAQ:BNGO) st... 
Via Benzinga
Is Bionano Genomics a Buy Ahead of Earnings?
Don’t mistake Bionano for just any Reddit stock. With its Q1 earnings looming, BNGO stock is attractively priced near its 2021 low. 
Via InvestorPlace
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
Don’t Look Now, but Bionano Genomics May Be a Buy
Bionano Genomics lost a lot of supporters in recent months and some never came to the rescue, but a lifeline has been thrown to BNGO stock. 
Via InvestorPlace
Don’t Confuse Bionano Genomics As an Investment Right Now
The science underlining BNGO stock is incredibly compelling. But that’s not what the market actually cares about right now. 
Via InvestorPlace
Bionano Genomics Has Disappointed, but Its NHS Deal May Turn Things Around
It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million... 
Via Benzinga
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.